11/01/2021
CD19/CD22 dual target car-t therapy

Hengrun Dashen CD19/CD22 dual target car-t therapy approved

Hengrun Dashen Class 1 biological new drug anti-human cd19-cd22 T cell injection has obtained implicit clinical trial license, and is intended to be developed for the treatment of relapsed/refractory B-cell acute lymphoblastic leukemia.
08/01/2021
drug

Scientists are expected to develop a new drug discovery strategy for “non drug” drug targets!

Recently, in a research report entitled "selection of DNA encoded chemical libraries against endogenous membrane proteins on live cells" published in the international journal Nature chemistry,scientists from Hong Kong University of China and other institutions have developed a new drug discovery method that can target live cell membrane proteins.
06/01/2021
new crown virus vaccine

China’s new crown virus vaccine was approved for listing

Relevant persons in charge of the Ministry of Science and Technology, the National Health Commission, the National Medical Products Administration, the Ministry of Foreign Affairs, the Ministry of Industry and Information Technology, experts in the vaccine research and development class, and the head of the Sinopharm Group introduced the new coronavirus vaccine and answered reporters’ questions.
05/01/2021
coronavirus vaccine

The first new coronavirus vaccine, 12 category 1 innovative drugs!

On December 30, the State Drug Administration conditionally approved the registration application of the new coronavirus inactivated vaccine (Vero cell) of the Sinopharm Beijing Institute of.
Biological Products Co., Ltd. This vaccine is the first domestically approved inactivated vaccine for the new coronavirus and is suitable for the prevention of the disease (COVID-19) caused by the new coronavirus infection.
04/01/2021
serum albumin

Research progress of recombinant human serum albumin

Human serum albumin is the most abundant protein in human plasma, accounting for 50%-60% of total plasma protein, with a concentration of 38-48g/L. It is the most important protein in human plasma.
HSA is a single-chain aglycosylated protein, composed of 585 amino acids, with a molecular weight of 66.5 kD and an isoelectric point between 4.7 and 4.9.
30/12/2020
coronavirus vaccine

The world’s largest biomedical IPO in 2020!

The record maker is Rongchang Biopharmaceutical (Yantai) Co., Ltd. After being listed on the Hong Kong Stock Exchange on November 9, Rongchang Bio-B (09995.HK) surprised the global capital market.
According to data at the end of November, the stock price rose by 34.36%, with a profit of HK$8,950 per lot, making it a dazzling star in the field of innovative drugs in Hong Kong stocks.
29/12/2020
coronavirus vaccine

A long way to go, 25 years of international innovation

On June 18, 2019, Luye Life Sciences Group celebrated its 25th birthday. As a pharmaceutical company under the group, Luye Pharma has gradually developed into an international pharmaceutical company dedicated to the research and development, production and sales of innovative drugs since its establishment in 1994.
28/12/2020
Mediterranean diet

Can the Mediterranean diet really improve human health?

Heart disease is the main cause of death for people in developed countries. There is research evidence that factors related to lifestyles such as diet may have a certain impact on the occurrence and development of such diseases.
18/12/2020
coronavirus vaccine

Nature:Don’t eat supper to have better memory

Recently, "Nature" magazine published online the latest research by Amita Sehgal and his research group at the University of Pennsylvania called "Availability of food determines the need for sleep in memory consolidation". The studyfound that the difficulty of obtaining food determines the size of the need for sleep in the process of memory consolidation.
BUY NOW